Barriers to timely access to care and possible cardiovascular (CV) complications associated with therapies used to treat inflammatory bowel disease (IBD), were identified by researchers and shared at the Crohn’s & Colitis Congress, the annual meeting of the Crohn’s & Colitis Foundation.
Inflammatory bowel disease is an umbrella term for Crohn disease and ulcerative colitis. Image credit: mi_viri – stock.adobe.com
Barriers to Health Care Access for Patients With IBD
Patients with IBD continue to experience challenges with accessing care, often having to skip or ration their medications as a result, which can have serious health consequences, according to 1 abstract.1
The researchers collected responses to an anonymous 52-question nationally-distributed survey. Patients with IBD as well as caretakers of this population…